Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 7/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | LIG1 | P18858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HPGDS | O60760 | 1/20 | 0.39 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.39 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4407685 | 0.88 | RAB9A (0.44) | DAOL3MBTL1KMT2AMEN1POLB | |
| SCHEMBL16056864 | 0.84 | DAO (0.42) | DAOL3MBTL1PKMLIG1KMT2A | |
| SCHEMBL5162659 | 0.84 | DAO (0.50) | DAOL3MBTL1PKMLIG1KMT2A | |
| SCHEMBL16401195 | 0.82 | DAO (0.46) | DAOL3MBTL1PKMLIG1KMT2A | |
| SCHEMBL432505 | 0.82 | L3MBTL1 (0.58) | DAOL3MBTL1PKMLIG1KMT2A | |
| SCHEMBL3960184 | 0.82 | DAO (0.48) | DAOL3MBTL1PKMLIG1KMT2A | |
| SCHEMBL1277482 | 0.82 | HDAC8 (0.66) | DAOPKMLIG1KMT2AHDAC8 | |
| SCHEMBL31955545 | 0.81 | L3MBTL1 (0.76) | DAOL3MBTL1PKMLIG1KMT2A | |
| SCHEMBL17057395 | 0.80 | DAO (0.43) | DAOL3MBTL1PKMLIG1KMT2A | |
| SCHEMBL3586108 | 0.80 | KDM4E (0.53) | L3MBTL1PKMKMT2AMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11565235-B2 | System and method for removing contaminants | YOUNGSTOWN STATE UNIVERSITY (US) | 2023-01-31 | — | — | US | disclosed |
| US-20200179905-A1 | SYSTEM AND METHOD FOR REMOVING CONTAMINANTS | YOUNGSTOWN STATE UNIVERSITY (US) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200179905-A1 | SYSTEM AND METHOD FOR REMOVING CONTAMINANTS | RIF1, ATF1, MUS81 | DAO 2075/4885L3MBTL1 1587/4885PKM 3119/4885 |
| US-11565235-B2 | System and method for removing contaminants | RIF1, ATF1, MUS81 | DAO 2075/4885L3MBTL1 1587/4885PKM 3119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.